Enzalutamide 40 mg Oral Tablet
RxNorm 2390644
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2390644 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: enzalutamide 40 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Enzalutamide 40 mg Oral Tablet
(Atom ID: 12425755)
PSNPrescribable
Prescribable Name (PSN):
Enzalutamide 40 mg Oral Tablet
(Atom ID: 12425760)
PTPrescribable
Designated preferred name (PT):
Enzalutamide 40 mg oral tablet
(Atom ID: 12871699)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely enzalutamide 40 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 12872111)
Patient Education
Enzalutamide
Enzalutamide is used to treat prostate cancer that has spread to other parts of the body in men and who have been helped by certain medical and surgical treatments that decrease testosterone levels. It is also used to treat prostate cancer in men who have not been helped by certain medical and surgical treatments that decrease testosterone levels. Enzalutamide is in a class of medications called androgen receptor inhibitors. It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells.
[Learn More]
* Please review the disclaimer below.